Asset
ABX-196
Abivax SA American Depositary Shares
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT03897543 | phase1_2 | recruiting | 2019-08-30 | 2021-06-30 | Abivax S.A. | ABX196 in Combination With Nivolumab in Patients With Hepatocellular Carcinoma |
FDA applications (0)
This company has no applications containing this asset.